Edition:
United States

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

1.23USD
16 Feb 2018
Change (% chg)

$0.01 (+0.82%)
Prev Close
$1.22
Open
$1.26
Day's High
$1.27
Day's Low
$1.15
Volume
35,145
Avg. Vol
23,477
52-wk High
$2.30
52-wk Low
$0.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 4.22 -0.272
Jun '17 6.48 -0.251
Mar '17 4.15 -0.308
FY 2016 Dec '16 2.69 -0.317
Sep '16 3.63 -0.292
Jun '16 5.05 -0.276
Mar '16 2.67 -0.378
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 8.50 8.50 8.50 7.10
Quarter Ending Jun-18 1 13.20 13.20 13.20 14.60
Year Ending Dec-18 2 36.30 45.60 27.00 45.32
Earnings (per share)
Quarter Ending Mar-18 1 -0.16 -0.16 -0.16 -0.15
Quarter Ending Jun-18 1 -0.12 -0.12 -0.12 -0.08
Year Ending Dec-18 2 -0.38 -0.19 -0.56 -0.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 20.62 23.34
P/E High - Last 5 Yrs. -- 26.71 156.12
P/E Low - Last 5 Yrs. -- 8.82 14.22
Beta 0.04 1.08 1.01
Price to Sales (TTM) 2.20 3.32 3.42
Price to Book (MRQ) -- 1.19 2.95
Price to Tangible Book (MRQ) -- 1.93 910.35
Price to Cash Flow (TTM) -- 15.71 18.04
% Owned Institutions 38.98 2.78 0.22

Dividends

  Company industry sector
Dividend Yield -- 1.31 2.13
Dividend Yield - 5 Year Avg -- 1.65 1.41
Dividend 5 Year Growth Rate -- 11.77 33.09
Payout Ratio(TTM) -- 14.57 50.44

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 16.10 -1.45 16.38
Sales (TTM) vs TTM 1 Yr. Ago 32.22 1.38 18.38
Sales - 5 Yr. Growth Rate 21.74 8.15 0.39
EPS (MRQ) vs Qtr. 1 Yr. Ago 6.91 65.30 13.47
EPS (TTM) vs TTM 1 Yr. Ago 17.75 -- --
EPS - 5 Yr. Growth Rate -- 14.26 24.10
Capital Spending - 5 Yr. Growth Rate -13.15 4.67 -2.71

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.36 0.37 2.05
Current Ratio (MRQ) 0.69 0.55 2.59
LT Debt to Equity (MRQ) -- 14.83 19.01
Total Debt to Equity (MRQ) -- 28.54 26.61
Interest Coverage (TTM) -3.66 20.40 27.73

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.82 30.48 25.42
Gross Margin - 5 Yr. Avg. 18.06 35.29 24.38
EBITD Margin (TTM) -124.79 -- --
EBITD - 5 Yr. Avg -323.88 15.46 19.67
Operating Margin (TTM) -136.64 4.80 13.22
Operating Margin - 5 Yr. Avg. -344.19 12.17 13.28
Pre-Tax Margin (TTM) -178.77 8.15 12.78
Pre-Tax Margin - 5 Yr. Avg. -404.60 11.23 13.01
Net Profit Margin (TTM) -178.77 6.14 9.80
Net Profit Margin - 5 Yr. Avg. -404.60 8.53 9.92
Effective Tax Rate (TTM) -- 17.27 18.37
Effective Tax Rate - 5 Yr. Avg. -- 22.65 27.32

Efficiency

  Company industry sector
Revenue/Employee (TTM) 180,814 17,384,523 7,010,440,989
Net Income/Employee (TTM) -323,237 1,635,718 897,849,891
Receivable Turnover (TTM) 8.94 3.65 8.36
Inventory Turnover (TTM) 1.17 1.48 6.20
Asset Turnover (TTM) 0.40 0.23 0.67

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -71.55 1.78 7.59
Return on Assets - 5 Yr. Avg. -70.18 8.25 7.40
Return on Investment (TTM) -133.46 2.59 9.65
Return on Investment - 5 Yr. Avg. -114.08 9.81 9.02
Return on Equity (TTM) -- 4.72 22.60
Return on Equity - 5 Yr. Avg. -- 18.82 10.83
  1 Year 3 Year 5 Year
Sales % 43.27 18.47 21.74
EPS (TTM) % 29.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Marrone Bio Innovations Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 21
Total Shares Held: 74,886,260
3 Mo. Net Change: 63,105,632
# New Positions: 3
# Closed Positions: 5
# Increased Positions: 7
# Reduced Positions: 8
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.